Etifoxine
Etifoxine, a non-benzodiazepine GABAergic compound, is a positive allosteric modulator of α1β2γ2 and α1β3γ2 subunit-containing GABAA receptors. Etifoxine reveals anxiolytic and anticonvulsant properties in rodents[1][2][3].
Product Specifications
CAS Number
21715-46-8
Product Name Alternative
HOE 36-801
UNSPSC
12352005
Hazard Statement
H302, H401
Target
GABA Receptor
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/etifoxine.html
Purity
99.27
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=CC=C2C(C(C3=CC=CC=C3)(C)OC(NCC)=N2)=C1
Molecular Formula
C17H17ClN2O
Molecular Weight
300.78
Precautions
H302, H401
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Citation 01
Psychopharmacology (Berl) . 2025 Jun;242 (6) :1303-1319.|Front Mol Neurosci. 2022 May 24:15:850904.|Glasgow Caledonian University. 2025.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human IgG Immunoglobulin (IG266), CF568 conjugate, 0.1mg/mL
Pmel17 / gp100 / SILV (NKI-beteb), CF568 conjugate, 0.1mg/mL
MART-1 / Melan-A (M2-7C10), CF488A conjugate, 0.1mg/mL
